MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$8,696,570
Short-term investments
$8,392,513
Tax and other
receivables
$1,793,459
Collaboration receivables
$1,522,770
Prepaid expenses and
other current assets
$1,141,804
Prepaid collaboration
expenses
$201,332
Total current assets
$21,748,448
Intangible assets and
in-process r&d, net
$2,063,100
Operating lease assets
with right-of-use
$285,827
Property and equipment,
net
$91,672
Other assets
$59,687
Restricted cash
$4,566
Total assets
$24,253,300
Total liabilities and
stockholders equity
$24,253,300
Total stockholders
equity
$16,126,536
Total liabilities
$8,126,764
Accumulated deficit
-$154,217,276
Accumulated other
comprehensive loss
-$246,137
Additional paid-in capital
$170,314,656
Total non-current
liabilities
$4,495,266
Total current
liabilities
$3,631,498
Common stock
$275,289
Preferred stock
$4
Contingent consideration
$2,939,316
Deferred collaboration
revenue
$1,250,000
Non-current operating lease
liabilities
$203,798
Deferred tax liability
$102,152
Accrued expenses
$2,406,731
Accounts payable
$1,060,306
Operating lease
liabilities
$164,461
Back
Back
Balance Sheet
source: myfinsight.com
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)